Translation. Region: Russian Federation –
Source: Novosibirsk State University –
An important disclaimer is at the bottom of this article.
Today, TASS-Siberia held a press conference to kick off a series of events dedicated to Russian Science Day, supported by the Russian Ministry of Science and Higher Education in regions ranging from Vladivostok to Kaliningrad. Participants included Deputy Governor Irina Manuilova; Rector of Novosibirsk State University, Doctor of Chemical Sciences, and Corresponding Member of the Russian Academy of Sciences Dmitry Pyshny; Director of the Institute of Chemical Biology and Fundamental Medicine, Doctor of Chemical Sciences Vladimir Koval; and Director of the Research Institute of Clinical and Experimental Lymphology (branch of the Institute of Cytology and Genetics SB RAS), Doctor of Medical Sciences Maxim Korolev. The press conference focused on the development of the scientific community in the region, advances in medical biotechnology, and promising areas of collaboration between Novosibirsk State University and the research institutes of the SB RAS.
The Deputy Governor noted the particular relevance of supporting the industry in the lead-up to Russian Science Day, celebrated on February 8, and the Decade of Science and Technology.
– The regional government’s most important priority is work within the framework of medical research projects. This work is being carried out within the framework of the national projects “Bioeconomics,” “New Materials and Chemistry,” and “New Health-Saving Technologies.” It will be further developed at the educational and scientific center of the Institute of Medicine and Medical Technologies of NSU, which is a second-stage facility. modern campus of NSU, being built as part of the national project "Youth and Children," Irina Manuilova emphasized.
In 2025, 33 projects were supported for a total of 123.5 million rubles. These include 24 projects implemented since 2024 and nine new projects. The supported projects are in healthcare, agriculture, housing and utilities, telecommunications, transportation, construction, and other sectors. In the region, research in medical biotechnology, including in youth laboratories for experimental and clinical pharmacology, molecular epidemiology, and viral biodiversity, is underway. The Immune Regulation Laboratory is developing cutting-edge technologies to improve the effectiveness of bone marrow transplantation, which will improve the quality of life, extend life expectancy, and reduce treatment costs.
Dmitry Pyshny, Rector of Novosibirsk State University and Doctor of Chemical Sciences and Corresponding Member of the Russian Academy of Sciences, emphasized the interdisciplinary nature of modern science and the university's role as a platform capable of bringing together specialists from various fields to implement major projects. He emphasized the need to strengthen the Novosibirsk Scientific Center's representation in federal scientific and technological development programs, such as genetic technology. It is also important to concentrate the region's existing research capabilities, both at universities and at SB RAS institutes, in other promising areas with potential for implementation in the real economy and the potential to improve people's lives, such as immunotherapy, cell technologies (CAR-T therapy), molecular diagnostics, genome editing, and agrobiotechnology. Akademgorodok boasts all the necessary resources for this, including leading research schools in biotechnology, bioorganic chemistry, organic chemistry, biomedicine, and industrial biotechnology.
Vladimir Koval, Director of the Institute of Chemical Biology and Fundamental Medicine and Doctor of Chemical Sciences, noted that mathematicians, physicists, chemists, and biologists—people capable of solving a multitude of interdisciplinary problems—work side by side in the Novosibirsk Akademgorodok. Currently, collaboration is at the forefront, with the goal, in particular, of developing drugs based on interfering RNA for the treatment of cancer.
Maxim Korolev also spoke about the unification of efforts between universities and research centers. He emphasized that modern biotechnology science is based on the evidence of multicenter research. In the Novosibirsk Region, Maxim Korolev identified two points of collective growth: the Siberian Biomedical Research Center and Novosibirsk State University, two important meeting points that can bring any ambitious project to fruition.
Last year, the Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, as part of a consortium led by the National Research Center "Kurchatov Institute," won a project under the "High-Tech Bioeconomy" program to use CAR T-cell technologies in a hospital-based approach to treat rheumatic diseases. The project involves the Research Institute of Fundamental and Clinical Immunology, the Institute of Molecular and Cell Biology of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk State University, and several industrial partners. NSU will receive the award in 2025 as part of the program. Priority 2030 program A laboratory has opened that will provide the new technology with a very important element: the creation of viral vectors that will overcome barriers when introducing genetic material into a cell.
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.